Printer Friendly

Printed from http://www.researchandmarkets.com/reports/1845399

NanoBio Corporation - Product Pipeline Review - Q2 2011

Description:

NanoBio Corporation – Product Pipeline Review – Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, “NanoBio Corporation - Product Pipeline Review - Q2 2011” provides data on the NanoBio Corporation’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, NanoBio Corporation’s corporate website, SEC filings, investor presentations and featured press releases, both from NanoBio Corporation and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- NanoBio Corporation - Brief NanoBio Corporation overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of NanoBio Corporation human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of NanoBio Corporation with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the NanoBio Corporation’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate NanoBio Corporation’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of NanoBio Corporation in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the NanoBio Corporation’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with NanoBio Corporation.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of NanoBio Corporation and identify potential opportunities in those areas.

Contents:

List of Tables
List of Figures
NanoBio Corporation Snapshot
NanoBio Corporation Overview
Key Information
Key Facts
NanoBio Corporation – Research and Development Overview
Key Therapeutic Areas
NanoBio Corporation – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
NanoBio Corporation – Pipeline Products Glance
NanoBio Corporation – Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
NanoBio Corporation Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
NanoBio Corporation–Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
NanoBio Corporation – Drug Profiles
NB-001
Product Description
Mechanism of Action
R&D Progress
NanoStat
Product Description
Mechanism of Action
R&D Progress
NB-002
Product Description
Mechanism of Action
R&D Progress
NB-002T
Product Description
Mechanism of Action
R&D Progress
NB-003
Product Description
Mechanism of Action
R&D Progress
NB-004
Product Description
Mechanism of Action
R&D Progress
NB-00X
Product Description
Mechanism of Action
R&D Progress
NB-1008
Product Description
Mechanism of Action
R&D Progress
Anthrax Vaccine
Product Description
Mechanism of Action
R&D Progress
Drug For Influenza Prophylaxis
Product Description
Mechanism of Action
R&D Progress
Drug For MRSA
Product Description
Mechanism of Action
R&D Progress
Nanoemulsion-Based Hepatitis B Vaccine
Product Description
Mechanism of Action
R&D Progress
NB-201
Product Description
Mechanism of Action
R&D Progress
Respiratory Syncytial Virus Vaccine
Product Description
Mechanism of Action
R&D Progress
Drug For Chronic Bronchitis
Product Description
Mechanism of Action
R&D Progress
Drug For Vaginitis
Product Description
Mechanism of Action
R&D Progress
NanoBio Corporation – Pipeline Analysis
NanoBio Corporation – Pipeline Products by Therapeutic Class
NanoBio Corporation - Pipeline Products By Target
NanoBio Corporation – Pipeline Products by Route of Administration
NanoBio Corporation – Pipeline Products by Molecule Type
NanoBio Corporation – Recent Pipeline Updates
NanoBio Corporation – Locations And Subsidiaries
Head Office
Financial Deals Landscape
NanoBio Corporation, Deals Volume Summary, 2004 to YTD 2011
NanoBio Corporation, Deals Summary By Region, 2004 to YTD 2011
NanoBio Corporation, Deals Summary, 2004 to YTD 2011
NanoBio Corporation Detailed Deal Summary
Venture Financing
NanoBio Raises $22 Million In Series B Round Of Financing
NanoBio Secures $10 Million In Final Tranche Of Financing
NanoBio Secures $10 Million In First Tranche Of Financing
Licensing Agreements
GlaxoSmithKline Enters Into Licensing Agreement With NanoBio
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
NanoBio Corporation – Pipeline by Therapy Area and Indication, 2011
NanoBio Corporation – Pipeline by Stage of Development, 2011
NanoBio Corporation – Monotherapy Products in Pipeline, 2011
NanoBio Corporation – Phase III, 2011
NanoBio Corporation - Phase II, 2011
NanoBio Corporation - Phase I, 2011
NanoBio Corporation - Pipeline By Therapeutic Class, 2011
NanoBio Corporation - Pipeline By Target, 2011
NanoBio Corporation – Pipeline By Route of Administration, 2011
NanoBio Corporation – Pipeline By Molecule Type, 2011
NanoBio Corporation – Recent Pipeline Updates, 2011
NanoBio Corporation, Deals Summary, 2004 to YTD 2011
NanoBio Corporation, Deals Summary by Region, 2004 to YTD 2011
NanoBio Corporation, Deals Summary, 2004 to YTD 2011

List of Figures
NanoBio Corporation – Pipeline by Therapy Area and Indication, 2011
NanoBio Corporation – Pipeline by Stage of Development, 2011
NanoBio Corporation – Monotherapy Products in Pipeline, 2011
NanoBio Corporation – Pipeline By Therapeutic Class, 2011
NanoBio Corporation - Pipeline By Target, 2011
NanoBio Corporation – Pipeline By Route of Administration, 2011
NanoBio Corporation – Pipeline By Molecule Type, 2011

Ordering:

Order Online - visit http://www.researchandmarkets.com/reports/1582661

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

Page 1 of 2

Printed Thursday, May 23, 2013
6:40:01 AM

Fax order form

To place a fax order simply print this form, fill in and fax the completed form to the number below. If you have any questions please email help@researchandmarkets.net

Order information

Please verify that the product information is correct and select the format you require.

Product name

NanoBio Corporation - Product Pipeline Review - Q2 2011

Web Address

http://www.researchandmarkets.com/reports/1845399

Office Code

OC8DIQSOQOVRYV

Report Formats

Please enter the quantity of the report format you require.

Format	Quantity	Price
Electronic (PDF) - Single User		EURO€ 384.00
Electronic (PDF) - Site License		EURO€ 769.00
Electronic (PDF) - Enterprisewide		EURO€ 1,153.00

Contact information

Please enter all the information below in block capitals.

                Title:
            
                    Mr
                    
                    Mrs
                    
                    Dr
                    
                    Miss
                    
                    Ms
                    
                    Prof
                    
                First Name:
            
                Last Name:
                
                Email Address:
            
                Job Title:
            
                Organisation:
            
                Address:
            
                City:
            
                Postal / Zip Code:	
            
                Country:	
            
                Phone Number:	
            
                Fax Number:

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)

Page 2 of 2

Printed Thursday, May 23, 2013
6:40:01 AM

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

Pay by Credit Card:

American Express

Diners Club

Master Card

Visa

Cardholder's Name:

Cardholder's Signature:

Expiry Date:

Card Number:

CVV Security Code:

Issue date:

(Diners Club only)

Pay by Check:

Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

Pay by Wire Transfer:

Please transfer funds to:

Account Number:

83313083

Sort Code:

98-53-30

Swift Code:

ULSBIE2D

IBAN Number:

IE78ULSB98533083313083

Bank Address:

Ulster Bank,
27-35 Main Street
Blackrock,
Co. Dublin
Ireland.

If you have a Marketing Code please enter it below:

Marketing Code:

Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Printer Friendly

NanoBio Corporation - Product Pipeline Review - Q2 2011

Fax order form

Order information

Product name

Web Address

Office Code

Report Formats

Contact information

Please fax this form to: (646) 607-1907 or (646) 964-6609 (from USA) +353-1-481-1716 or +353-1-653-1571 (from Rest of World)

Payment information

Please fax this form to: (646) 607-1907 or (646) 964-6609 (from USA) +353-1-481-1716 or +353-1-653-1571 (from Rest of World)

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)